Identification of Cutibacterium modestum in Spondylitis by Metagenomics Analysis

In Vivo. 2023 May-Jun;37(3):1384-1388. doi: 10.21873/invivo.13221.

Abstract

Background/aim: Identifying pathogens with culture-negative pyogenic spondylitis is difficult. Shotgun metagenomic sequencing is an unbiased and culture-free approach in the diagnosis of infectious diseases. There are, however, a variety of contaminating factors that can confound the precision of metagenomic sequencing.

Case report: In a 65-year-old man suffering from culture-negative L3-5 spondylitis, metagenomics was applied to facilitate the diagnosis. The patient underwent percutaneous endoscopic lumbar discectomy. We applied metagenomic sequencing with a robust contamination-free protocol to the bone biopsy. By comparing the abundance for each taxon between the replicates and negative controls, we reliably identified Cutibacterium modestum as having a statistically higher abundance in all replicates. The patient's antibiotic therapy was switched to penicillin and doxycycline based upon the resistome analysis; the patient fully recovered.

Conclusion: This application of next-generation sequencing provides a new perspective in the clinical approach to spinal osteomyelitis and illustrates the potential of this technique in rapid etiological diagnosis.

Keywords: Cutibacterium modestum; antibiotic-resistant genes; culture-negative pyogenic spondylitis; resistome; shotgun metagenomic sequencing.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Diskectomy, Percutaneous*
  • High-Throughput Nucleotide Sequencing / methods
  • Humans
  • Intervertebral Disc Displacement*
  • Lumbar Vertebrae
  • Male
  • Spondylitis* / diagnosis

Supplementary concepts

  • Propionibacterium humerusii